Document Detail


Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme.
MedLine Citation:
PMID:  22469987     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The infiltration of glioma cells into adjacent tissue is one of the major obstacles in the therapeutic management of malignant brain tumours, in most cases precluding complete surgical resection. Consequently, malignant glioma patients almost invariably experience tumour recurrences. Within the brain, glioma cells migrate rapidly either amoeboidly or mesenchymally to invade surrounding structures, in dependence on the extracellular environment. In addition, radiotherapy, frequently applied as adjuvant therapeutic modality, may enhance tumour cell mobility. Here, we show that the receptor tyrosine kinase Mer (MerTK) is overexpressed in glioblastoma multiforme (GBM) and that this is accompanied with increased invasive potential. MerTK expression is maintained in primary GBM-derived tumour spheres under stem cell culture conditions but diminishes significantly in serum-containing cultures with concomitant downregulation of Nestin and Sox2. Depletion of MerTK disrupts the rounded morphology of glioma cells and decreases their invasive capacity. Furthermore, the expression and phosphorylation of myosin light chain 2 are strongly associated with MerTK activity, indicating that the effect of MerTK on glioma cell invasion is mediated by actomyosin contractility. Finally, DNA damage robustly triggers the upregulation and phosphorylation of MerTK, which protects cells from apoptosis. This effect is strongly impaired upon MerTK depletion or overexpression of an inactive MerTK mutant. Collectively, our data suggests that MerTK is a novel therapeutic target in the treatment of the malignant gliomas.Oncogene advance online publication, 2 April 2012; doi:10.1038/onc.2012.104.
Authors:
Y Wang; G Moncayo; P Morin; G Xue; M Grzmil; M M Lino; V Clément-Schatlo; S Frank; A Merlo; B A Hemmings
Related Documents :
9536047 - Effect of atp sulfurylase overexpression in bright yellow 2 tobacco cells. regulation o...
10926287 - Functional mitochondrial heterogeneity in heteroplasmic cells carrying the mitochondria...
18047827 - Control of cell respiration by nitric oxide in ataxia telangiectasia lymphoblastoid cells.
10365247 - Mitochondrial changes during the apoptotic process of hela cells exposed to cisplatin.
22743247 - Bioactivation of the citrus flavonoid nobiletin by cyp1 enzymes in mcf7 breast adenocar...
24736847 - Root growth is modulated by differential hormonal sensitivity in neighboring cells.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-02
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Mechanisms of Cancer, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rage signalling promotes intestinal tumourigenesis.
Next Document:  miR-143 regulates hexokinase 2 expression in cancer cells.